COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,100 Articles (22,658 medRxiv, 8,442 bioRxiv)

Most recent first Previous |  Page 224: Articles 2231-2240  | Next

Quantitating SARS-CoV-2 Neutralizing Antibodies from Human Dried Blood Spots
Berman, K., Van Slyke, G., Novak, H., Rock, J., Bievenue, R., Damjanovic, A., DeRosa, K., Mirabile, G., Giradin, R., Dupuis, A., McDonough, K., Parker, M. M., Styer, L., MANTIS, N. J.
10.1101/2024.03.18.585599 — Posted: 2024-03-20
"She helped from the first minute to the last" - experiences of respectful maternal and newborn care during the COVID-19 pandemic in Nampula Province, Mozambique
Lydon, M. M., Vilanculos, J., Crew, C., Barata, A., Keyes, E.
10.1101/2024.03.19.24304557 — Posted: 2024-03-20
Navigating stroke care during the COVID-19 pandemic: A scoping review
Menard, A., Yang, M., Oostlander, S., Sarwal, K., Manji, I., O'Sullivan, T., Fraser, S.
10.1101/2024.03.19.24304563 — Posted: 2024-03-20
Evaluation of Febrile Seizure Risk Following Ancestral Monovalent COVID-19 mRNA Vaccination Among U.S. Children Aged 2-5 Years
Forshee, R. A., Smith, E. R., Wan, Z., Amend, K. L., Secora, A., Djibo, D. A., Kazemi, K., Song, J., Parlett, L. E., Seeger, J. D., Selvam, N., McMahill-Walraven, C. N., Hu, M., Chillarige, Y., Anderson, S. A.
10.1101/2024.03.12.24304127 — Posted: 2024-03-19
H2 inhalation therapy in patients with moderate Covid 19 (H2 COVID) : a prospective ascending-dose phase 1 clinical trial
Salomez-Ihl, C., Giai, J., Barbado, M., Paris, A., Touati, S., Alcaraz, J.-P., Tanguy, S., Leroy, C., Lehmann, A., Degano, B., Gavard, M., Bedouch, P., Pavese, P., Moreau-Gaudry, A., Roustit, M., Boucher, F., Cinquin, P., Brion, J.-P.
10.1101/2024.03.15.24304071 — Posted: 2024-03-19
COVID-19 Impact on Patients with Immune-Mediated Rheumatic Disease: A Comparative Study of Disease Activity and Psychological Well-Being Over Six Months
MARQUES, C. D. L., Pinheiro, M., Lopes, J., Ribeiro, S. L. E., Castro, M. V. M., Valadares, L. D. d. A., Ranzolin, A., de Andrada, N. P. B., do Espirito Santo, R. C., Araujo, N. C., Vieira, C. M., Valim, V., Santos, F., da Rocha Junior, L. F., Kakehasi, A. M., Monteiro Gomides Reis, A. P., Torres Neto, E., Pilegii, G., Ferreira, G. A., Mota, L., Monticielo, O., Xavier, R. M.
10.1101/2024.03.18.24304464 — Posted: 2024-03-19
Integrated multiomics implicates dysregulation of ECM and cell adhesion pathways as drivers of severe COVID-associated kidney injury
Anandakrishnan, N., Yi, Z., Sun, Z., Liu, T., Haydak, J., Eddy, S., Jayaraman, P., Defronzo, S., Saha, A., Sun, Q., Dai, Y., Mendoza, A., Mosoyan, G., Wen, H. H., Schaub, J. A., Fu, J., Kehrer, T., Menon, R., Otto, E. A., Godfrey, B., Suarezfarinas, M., Lefferts, S., Twumasi, A., Meliambro, K., Charney, A., Garcia-Sastre, A., Campbell, K., Gusella, L. G., He, J., Miorin, L., Nadkarni, G., Wisnivesky, J. P., Li, H., Kretzler, M., Coca, S., Chan, L., Zhang, W., Azeloglu, E. U.
10.1101/2024.03.18.24304401 — Posted: 2024-03-19
COVID-19-associated acute renal failure in critically ill patients correlates with microthrombosis and renal loss of thrombomodulin
Koskinen, M., Englund, E., Korkut, G. G., Schwarz, A., Jeansson, M.
10.1101/2024.03.18.24304157 — Posted: 2024-03-19
The impact of wildtype SARS-CoV-2 on fatigue and quality of life: prevalence of post COVID-19 condition in a Dutch population-based serosurveillance cohort.
Mutubuki, E. N., van Hagen, C. C. E., Vos, E. R. A., den Hartog, G., van der Klis, F. R. M., van den Wijngaard, C. C., de Melker, H. E., van Hoek, A. J.
10.1101/2024.03.19.24304303 — Posted: 2024-03-19
The Impact of Cognitive Function on Health-Related Quality of Life in Persons with Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine
Kwan, A. T. H., Lakhani, M., Le, G. H., Singh, G., Teopiz, K. M., Guo, Z., Manku, A. S., Rosenblat, J. D., McIntyre, R. S.
10.1101/2024.03.18.24304375 — Posted: 2024-03-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).